Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"

Affiliations

¹ Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
² Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
³ Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
⁴ Duke University Medical Center, Durham, North Carolina, USA.
⁵ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
⁶ Division of Infectious Diseases Department of Medicine, Irvine School of Medicine, University of California, Irvine, California, USA.
⁷ Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
⁸ Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
⁹ Sanofi Pasteur, Swiftwater, Pennsylvania, USA.
¹⁰ Novartis Vaccines and Diagnostics, Inc., Cambridge, Massachusetts, USA.
¹¹ Advanced BioScience Laboratories, Inc., Rockville, Maryland, USA.
¹² EuroVacc Foundation, Lausanne, Switzerland.
¹³ Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
¹⁴ Institute of Clinical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
¹⁵ School of Life Sciences, Arizona State University, Tempe, Arizona, USA.

Published Erratum

Karen V Kibler et al. J Virol. 2019.

. 2019 Oct 15;93(21):e00968-19.

doi: 10.1128/JVI.00968-19. Print 2019 Nov 1.

¹ Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
² Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
³ Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
⁴ Duke University Medical Center, Durham, North Carolina, USA.
⁵ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
⁶ Division of Infectious Diseases Department of Medicine, Irvine School of Medicine, University of California, Irvine, California, USA.
⁷ Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
⁸ Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
⁹ Sanofi Pasteur, Swiftwater, Pennsylvania, USA.
¹⁰ Novartis Vaccines and Diagnostics, Inc., Cambridge, Massachusetts, USA.
¹¹ Advanced BioScience Laboratories, Inc., Rockville, Maryland, USA.
¹² EuroVacc Foundation, Lausanne, Switzerland.
¹³ Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
¹⁴ Institute of Clinical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
¹⁵ School of Life Sciences, Arizona State University, Tempe, Arizona, USA.

No abstract available

Erratum for

Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
Kibler KV, Asbach B, Perdiguero B, García-Arriaza J, Yates NL, Parks R, Stanfield-Oakley S, Ferrari G, Montefiori DC, Tomaras GD, Roederer M, Foulds KE, Forthal DN, Seaman MS, Self S, Gottardo R, Phogat S, Tartaglia J, Barnett S, Cristillo AD, Weiss D, Galmin L, Ding S, Heeney JL, Esteban M, Wagner R, Pantaleo G, Jacobs BL. Kibler KV, et al. J Virol. 2019 Jan 17;93(3):e01513-18. doi: 10.1128/JVI.01513-18. Print 2019 Feb 1. J Virol. 2019. PMID: 30429340 Free PMC article.